| 1 |
Ma SC, Zhang JQ, Yan TH, Miao MX, Cao YM, Cao YB, Zhang LC, Li L. Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med 2023. [PMID: 36645225 DOI: 10.1002/cam4.5594] [Reference Citation Analysis]
|
| 2 |
Ma X, Sun X, Wang R, Guo Y, Xu M. Effects of curcumin on 5-fluorouracil resistance of colon cancer cells through the PI3K/AKT/mTOR pathway via MACC1. European Journal of Integrative Medicine 2022;56:102202. [DOI: 10.1016/j.eujim.2022.102202] [Reference Citation Analysis]
|
| 3 |
Li Y, Zhang H, Long W, Gao M, Guo W, Yu L. Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo. Aging 2022. [DOI: 10.18632/aging.204363] [Reference Citation Analysis]
|
| 4 |
Giansanti MG, Piergentili R. Linking GOLPH3 and Extracellular Vesicles Content-a Potential New Route in Cancer Physiopathology and a Promising Therapeutic Target is in Sight? Technol Cancer Res Treat 2022;21:15330338221135724. [PMID: 36320176 DOI: 10.1177/15330338221135724] [Reference Citation Analysis]
|
| 5 |
Zhao B, Tang K, Zhao Y, Zhao W, Kumar V. Senkyunolide H Affects Cerebral Ischemic Injury through Regulation on Autophagy of Neuronal Cells via P13K/AKT/mTOR Signaling Pathway. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/9211621] [Reference Citation Analysis]
|
| 6 |
Huo Y, Cao K, Kou B, Chai M, Dou S, Chen D, Shi Y, Liu X. TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.08.014] [Reference Citation Analysis]
|
| 7 |
Kreft ME, Mironov AA, Hudoklin S. The Golgi complex: An organelle that determines urothelial cell biology in health and disease. Histochem Cell Biol 2022. [PMID: 35773494 DOI: 10.1007/s00418-022-02121-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Hong Z, Pan J, Chen M, Deng X, Chen Z, Wang C, Qiu C. Long Intergenic Noncoding RNA 00641 Promotes Growth and Invasion of Colorectal Cancer through Regulating miR-450b-5p/GOLPH3 Axis. J Oncol 2022;2022:8259135. [PMID: 35756081 DOI: 10.1155/2022/8259135] [Reference Citation Analysis]
|
| 9 |
Sahu P, Balakrishnan A, Di Martino R, Luini A, Russo D. Role of the Mosaic Cisternal Maturation Machinery in Glycan Synthesis and Oncogenesis. Front Cell Dev Biol 2022;10:842448. [DOI: 10.3389/fcell.2022.842448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Gong LY, Tu T, Zhu J, Hu AP, Song JW, Huang JQ, Yang Y, Zhu Z, Chen Y. Golgi phosphoprotein 3 induces autophagy and epithelial-mesenchymal transition to promote metastasis in colon cancer. Cell Death Discov 2022;8:76. [PMID: 35190555 DOI: 10.1038/s41420-022-00864-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Lin L, He Y, Ni Z, Zhang M, Liu J, Mao Q, Huang B, Lin J. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma. Open Medicine 2022;17:304-16. [DOI: 10.1515/med-2022-0421] [Reference Citation Analysis]
|
| 12 |
Gao Y, Yin Z, Qi Y, Peng H, Ma W, Wang R, Li W. Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02462-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Deng C, Hu F, Zhao Z, Zhou Y, Liu Y, Zhang T, Li S, Zheng W, Zhang W, Wang T, Ma X. The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance. Front Cell Dev Biol 2021;9:797005. [PMID: 35047507 DOI: 10.3389/fcell.2021.797005] [Reference Citation Analysis]
|
| 14 |
He J, Liu J, Huang Y, Tang X, Xiao H, Liu Z, Jiang Z, Zeng L, Hu Z, Lu M. OM-MSCs Alleviate the Golgi Apparatus Stress Response following Cerebral Ischemia/Reperfusion Injury via the PEDF-PI3K/Akt/mTOR Signaling Pathway. Oxid Med Cell Longev 2021;2021:4805040. [PMID: 34815829 DOI: 10.1155/2021/4805040] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 15 |
Li Q, Sun H, Luo D, Gan L, Mo S, Dai W, Liang L, Yang Y, Xu M, Li J, Zheng P, Li X, Li Y, Wang Z. Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res 2021;40:348. [PMID: 34740372 DOI: 10.1186/s13046-021-02143-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Zhang Y, Jia H, Liu Z, Guo J, Li Y, Li R, Zhu G, Li J, Li M, Li X, Wang S, Dang C, Zhao T. D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer. Int Immunopharmacol 2021;101:108203. [PMID: 34649091 DOI: 10.1016/j.intimp.2021.108203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Lin Q, Luo L, Wang H. A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling. Front Oncol 2021;11:644956. [PMID: 34026619 DOI: 10.3389/fonc.2021.644956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Zhu Z, Zhu Q, Cai D, Chen L, Xie W, Bai Y, Luo K. Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome. Oncol Rep 2021;45:113. [PMID: 33907835 DOI: 10.3892/or.2021.8064] [Reference Citation Analysis]
|
